U.S. markets close in 1 hour 53 minutes

  • S&P 500

    4,239.42
    +14.63 (+0.35%)
     

  • Dow 30

    33,910.68
    +33.71 (+0.10%)
     

  • Nasdaq

    14,208.70
    +67.22 (+0.48%)
     

  • Russell 2000

    2,282.40
    -3.69 (-0.16%)
     

  • Crude Oil

    73.04
    -0.62 (-0.84%)
     

  • Gold

    1,778.40
    -4.50 (-0.25%)
     

  • Silver

    25.88
    -0.15 (-0.58%)
     

  • EUR/USD

    1.1942
    +0.0017 (+0.14%)
     

  • 10-Yr Bond

    1.4770
    -0.0070 (-0.47%)
     

  • GBP/USD

    1.3942
    +0.0009 (+0.07%)
     

  • USD/JPY

    110.6880
    +0.3900 (+0.35%)
     

  • BTC-USD

    32,463.70
    +53.01 (+0.16%)
     

  • CMC Crypto 200

    772.53
    -21.80 (-2.74%)
     

  • FTSE 100

    7,090.01
    +27.72 (+0.39%)
     

  • Nikkei 225

    28,884.13
    +873.20 (+3.12%)
     

Breckenridge Signs Multi-Product Agreement With Aggrega Pharma LLC

·2 min read

BERLIN, Conn., June 22, 2021 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announces today that it has signed a multi-product agreement with Aggrega Pharma, LLC. under which Aggrega will develop, manufacture and supply pharmaceutical products for marketing, sale and distribution by Breckenridge. The agreement currently covers eight products in a variety of dosage forms, including solid oral, nasal spray, ophthalmic, injectable and transdermal products. For these eight products, one ANDA has been approved, four ANDAs have been submitted to the U.S. Food and Drug Administration and three ANDAs are at advanced stages of development. Breckenridge previously launched Succinylcholine Chloride Injection, USP, 20mg/mL under this agreement, which is now available from Breckenridge as a carton of 25 vials. According to industry sales data, these eight products and their generics had annual sales of $500 million during the twelve months ending April 2021.

(PRNewsfoto/Breckenridge Pharmaceutical, Inc.)
(PRNewsfoto/Breckenridge Pharmaceutical, Inc.)

About Breckenridge:
Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical (Osaka, Japan), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients. With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and quality of life of the patients we and our customers serve.
www.bpirx.com

About Aggrega Pharma, LLC:
Aggrega Pharma, LLC. is a first-class pharmaceutical company developing, manufacturing and marketing generic medications (injectable, ophthalmic, oral and topical finished dosage forms). The shareholders are 4 European companies: Bluepharma, Rafarm, Substipharm and Welding. Aggrega Pharma is committed to building a pipeline of complex and selected generic products by leveraging the vast R&D, clinical and manufacturing experience and capabilities of its members. Our portfolio includes products that are commercialized as well as products to be launched soon.
www.aggregapharma.com

For further information, please contact:
Breckenridge Pharmaceutical, Inc.
Robert Gasparino, Associate Vice President – Business Development
Tel: 860-828-8140
E-mail: rgasparino@bpirx.com

*All brand names and trademarks are the property of their respective owners.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/breckenridge-signs-multi-product-agreement-with-aggrega-pharma-llc-301317634.html

SOURCE Breckenridge Pharmaceutical, Inc.

Recommended Stories

  • Angst at Exxon as managers begin employee performance reviews

    HOUSTON/BENGALURU (Reuters) -Top U.S. oil producer Exxon Mobil Corp has kicked off a yearly performance review for U.S. staff, a process some workers dread because they view it this year as a prelude to stealth layoffs. The evaluations are expected to assign about 5% to 10% of the workforce to performance improvement plans that can lead to forced departures for those unable to achieve managers' goals, according to a person familiar with the process. Exxon last year targeted 8% of U.S. employees as low performers - up from 3% historically.

  • I’m 60 and earn $150K passive income. I want my wife, 50, to travel with me in an RV, but she won’t quit her job. What can I do?

    ‘My wife earns about $35,000 a year. She's stated that she doesn't want to let her employer down by quitting.’

  • What in the heck is the FDA thinking?

    By John Vandermosten, CFA TSX:PMN.TO | OTC:ARFXF | NASDAQ:BIIB One of the wildest roller coaster rides in biotech has been the aducanumab saga that has been taking place over the last few years. Aducanumab, branded as Aduhelm, is an amyloid beta-directed monoclonal antibody intended for use in the treatment of Alzheimer’s Disease (AD). Aduhelm binds to aggregated forms of amyloid beta and has

  • Exclusive: Google drops engineering residency after protests over 'inequities'

    Alphabet Inc's Google plans to shut down a long-running program aimed at entry-level engineers from underrepresented backgrounds after participants said it enforced "systemic pay inequities," according to internal correspondence seen by Reuters. Google confirmed it was replacing the Engineering Residency with a new initiative, saying it is "always evaluating programs to ensure they evolve and adapt over time to meet the needs of our employees." Google last year pledged to improve retention for underrepresented employee groups.

  • From Doubts And Struggles To International Recognition: Building One The Biggest Crypto Publications In The World

    Victoria Vaughan (Arsenova) is a former CEO of Cointelegraph, who was in charge of growing the brand from a very small brand to a worldwide company. How It All Started Victoria had never heard about cryptocurrency before 2012. Not a lot of people did. She was working at a tech startup at the time, and part of her job included attending international conferences. During one of the events, she was approached by a tech geek who tried to explain to her what this whole “crypto thing” is and why it’s

  • Exxon Doubles Down On World’s Hottest Offshore Play

    Supermajors are piling into the world’s hottest offshore drilling location after a string of major discoveries

  • Covid-19 Showed mRNA Vaccines Work. Translate Bio, Sanofi, Are Testing One for Flu.

    The world has settled for flu vaccines that are no more than 50% effective, so a better product could reshape the market, and perhaps expand it.

  • Oil Could Get to $100 a Barrel. Here Are the Stocks to Play It.

    Bank of America lifts its price forecasts and likes Exxon Mobil, Occidental, Hess, Diamondback Energy, and Devon Energy.

  • Why office perks are not enough to stop staff burning out

    Kombucha on tap, free healthy lunches and blowouts every other Friday. Those are just some of the perks that Whitney Wolfe Herd has given her employees at Bumble, the dating app recently valued at $8.3bn (£6bn). The 31-year-old founder, who is the world’s youngest self-made female billionaire, has over the years taken care to craft an image of a company that promises to look after its employees. “I’ve never felt like I need to hide the fact that I’m a working mom or that I’m held back profession

  • Labor shortage impacting airlines’ summer travel

    Mike Boyd, Boyd Group International President, joins Yahoo Finance to discuss the labor shortage impact on airlines amid pandemic recovery and outlook on summer travel.

  • Amazon and Apple are the most valuable brands in the world — but these Chinese companies are catching up

    These are the top 100 most valuable global brands for 2021, according to a company that analyzes brand equity

  • TradeDesk vs.Alphabet: Which “Strong Buy” Targeted Ads Stock Will Fetch Higher Returns?

    Targeted advertising is increasingly being favored by advertisers, as it allows them to monetize user data effectively. However, in some cases, it is also giving rise to data privacy concerns leading to companies coming up with innovative solutions to monetize user data without compromising on privacy concerns. Using the TipRanks Stock Comparison tool, we will compare two companies that provide targeted advertising services, theTradeDesk and Alphabet, and see how Wall Street analysts feel about

  • Amazon’s breakup faces ‘long odds,’ says 'Amazon Unbound' author Brad Stone

    Author Brad Stone says it's unlikely Amazon will be broken up over any alleged antitrust violations.

  • Chinese Bitcoin Mining Company Delivers First Machines to Kazakhstan

    BIT Mining expects to deliver another two batches of machines by the start of July.

  • Rates Are Still Low. Here Are 8 Large-Cap Stocks That Offer Income.

    High-yielding stocks are back in vogue this year as investors hunt for dividends in a low-rate environment and favor value-oriented strategies. Barron’s screened the S&P 500 based on data from S&P Dow Jones Indices for top-yielding stocks and came up with eight companies with dividends in the range of 5% to 7%. Wolfe Research strategist recently noted that high-yielding stocks were historically inexpensive versus the S&P 500 based on price earnings ratios.

  • Fireblocks Being Sued for Allegedly Losing Over $70M of Ether: Report

    A Fireblocks employee allegedly did not protect or back up private keys to a digital wallet, which were then deleted.

  • Oracle to Offer Credits on Support Contracts to New Cloud Database Customers

    Think of it as a frequent-flier program for (ORCL) database customers. At a virtual event later today, Oracle (ticker: ORCL) is set to announce Oracle Support Rewards, a program that will provide credits for support costs to customers that shift workloads to the Oracle Cloud or add brand new cloud-based work. When Oracle reported earnings last week, CEO Safra Catz said the company plans to nearly double capital spending on its cloud business for the May 2022 fiscal year to $4 billion, building out infrastructure to keep up with growth of better than 100% a year.

  • Nokia to allow employees to work remotely for three days a week

    Nokia said its employees can choose to work up to three days a week remotely with increased support for flexible working hours from January after its current work from home policy comes to an end in December. The Finnish telecom equipment maker conducted a survey of its employees at the end of last year and a majority said they wanted to work two to three days per week remotely, up from an average of two days before the coronavirus pandemic. The company, which had about 92,000 employees in 130 countries at the end of 2020, said in March it plans to cut up to 10,000 jobs within two years to trim costs and invest more in research capabilities.

  • The Underdog in the EV Arms Race

    Photo by Waldemar Brandt on Unsplash It certainly feels like the auto industry’s future is going to be electric, as top car manufacturers focus on developing robust EV product lines, and new government incentives for EV owners roll out seemingly every week. As these vehicles become more popular, finding the best ways to capitalize on the growth of the industry could be a very profitable endeavor. While investors tend to gravitate toward the companies that sell these electric vehicles such as Tes

  • Exclusive-Google drops engineering residency after protests over 'inequities'

    Alphabet Inc's Google plans to shut down a long-running program aimed at entry-level engineers from underrepresented backgrounds after participants said it enforced "systemic pay inequities," according to internal correspondence seen by Reuters. Google confirmed it was replacing the Engineering Residency with a new initiative, saying it is "always evaluating programs to ensure they evolve and adapt over time to meet the needs of our employees." Google last year pledged to improve retention for underrepresented employee groups.